BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Epidermal growth factor receptor mutation
1
Coexistence of anaplastic lymphoma kinase rearrangement in lung adenocarcinoma harbouring epidermal growth factor receptor mutation: A single-center study
11/23/2022 9:44:44 AM | Browse: 136 | Download: 270
2
Early detection of circulating tumor DNA and successful treatment with osimertinib in thr790met-positive leptomeningeal metastatic lung cancer: A case report
7/22/2022 7:03:59 AM | Browse: 205 | Download: 281
3
Sequential chemotherapy and icotinib as first-line treatment for advanced epidermal growth factor receptor-mutated non-small cell lung cancer
6/17/2022 3:19:26 AM | Browse: 217 | Download: 460
4
Dramatic response to immunotherapy in an epidermal growth factor receptor-mutant non-small cell lung cancer: A case report
12/23/2021 2:14:14 PM | Browse: 193 | Download: 465
5
Histological transformation of non-small cell lung cancer: Clinical analysis of nine cases
6/11/2021 9:22:17 AM | Browse: 208 | Download: 352
6
Significant benefits of osimertinib in treating acquired resistance to first-generation EGFR-TKIs in squamous cell lung cancer: A case report
5/26/2019 9:49:23 AM | Browse: 790 | Download: 1393
7
FDG-PET for predicting efficacy of EGFR-tyrosine kinase inhibitors in lung cancer
9/15/2014 4:56:00 PM | Browse: 992 | Download: 1013
8
EGFR mutation identifies distant squamous cell carcinoma as metastasis from lung adenocarcinoma
9/15/2014 4:47:00 PM | Browse: 1021 | Download: 869
9
Management of tyrosine kinase inhibitor resistance in lung cancer with EGFR mutation
8/22/2014 5:28:00 PM | Browse: 1085 | Download: 1017
10
Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer
8/22/2014 5:28:00 PM | Browse: 879 | Download: 728
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345